Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
| Actual shortage: | 232 (8%) | |
| Anticipated shortage: | 15 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CANDESARTAN | 32MG | TABLET | Resolved | 2017-03-20 | 2020-02-25 | 3516 |
| APO-CICLESONIDE | 50MCG | SPRAY, METERED DOSE | Resolved | 2017-03-20 | 2019-01-03 | 3520 |
| APO-PAROXETINE | 20MG | TABLET | Resolved | 2017-03-20 | 2017-07-11 | 3529 |
| APO-PRAVASTATIN | 10MG | TABLET | Resolved | 2017-03-20 | 2017-04-24 | 3533 |
| APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2017-03-20 | 2017-03-24 | 3539 |
| APO-CIPROFLOX | 500MG | TABLET | Resolved | 2017-03-20 | 2017-06-12 | 3619 |
| APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Resolved | 2017-03-20 | 2017-05-02 | 3622 |
| APO-TOPIRAMATE | 100MG | TABLET | Resolved | 2017-03-21 | 2017-03-21 | 3746 |
| APO-MIDODRINE | 2.5MG | TABLET | Resolved | 2017-03-21 | 2017-04-14 | 3800 |
| APO-MIRTAZAPINE | 15MG | TABLET | Resolved | 2017-03-22 | 2017-05-02 | 3909 |
| APO-MIDODRINE | 5.0MG | TABLET | Resolved | 2017-03-28 | 2017-04-14 | 4521 |
| APO-EZETIMIBE | 10MG | TABLET | Resolved | 2017-04-04 | 2017-04-25 | 5366 |
| APO-DONEPEZIL | 5MG | TABLET | Resolved | 2017-04-04 | 2017-07-24 | 5402 |
| APO-OXYBUTYNIN | 5MG | TABLET | Resolved | 2017-04-07 | 2018-11-30 | 5865 |
| APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2017-04-07 | 2017-12-11 | 5888 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2017-04-07 | 2017-06-27 | 5891 |
| APO-GABAPENTIN | 400MG | CAPSULE | Resolved | 2017-04-07 | 2017-09-15 | 5897 |
| APO-MEDROXY | 10MG | TABLET | Resolved | 2017-04-07 | 2017-05-18 | 5997 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2017-04-07 | 2017-06-09 | 6000 |
| APO-CICLESONIDE | 50MCG | SPRAY, METERED DOSE | Resolved | 2017-04-11 | 2018-12-20 | 6414 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4965 |
| APO-OLANZAPINE | 5.0MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4968 |
| APO-SOTALOL | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
| APO-TERAZOSIN | 2MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4974 |
| APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
| DOCUSATE SODIUM CAPSULES | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2018-09-15 | 40738 |
| APO-FENTANYL MATRIX | 100MCG | PATCH | Discontinued | 2018-02-23 | 2018-12-28 | 40741 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
| APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40781 |
| APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40784 |
| APO-METFORMIN | 500MG | TABLET | Discontinued | 2018-02-23 | 2018-11-26 | 40790 |
| APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40811 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40814 |